Avalon GloboCare Corp. Files 8-K on Shareholder Matters

Ticker: ALBT · Form: 8-K · Filed: Oct 11, 2024 · CIK: 1630212

Sentiment: neutral

Topics: corporate-governance, filing, shareholder-vote

TL;DR

Avalon GloboCare filed an 8-K on shareholder votes. Stay tuned.

AI Summary

Avalon GloboCare Corp. filed an 8-K on October 11, 2024, reporting on matters submitted to a vote of its security holders as of October 7, 2024. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).

Why It Matters

This filing provides an update on corporate governance and shareholder voting, which can impact investor confidence and the company's strategic direction.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not indicate any immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Avalon GloboCare Corp.'s security holders?

The filing indicates that matters were submitted to a vote, but the specific details of these matters are not provided in the provided text excerpt.

When did the events related to the shareholder vote occur?

The earliest event reported in the filing occurred on October 7, 2024.

What is Avalon GloboCare Corp.'s principal executive office address?

The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

What is the company's primary business classification?

The company is classified under Biological Products (No Diagnostic Substances) [2836].

Has Avalon GloboCare Corp. had previous names?

Yes, the company was formerly known as Avalon Globocare Corp. (name change effective October 18, 2016) and prior to that, Global Technologies Corp. (name change effective January 8, 2015).

Filing Stats: 1,143 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2024-10-11 16:30:07

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: October 11, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing